LABCORP HOLDINGS INC. Income Taxes Disclosure
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Domestic | $ | 728.9 | $ | 629.7 | $ | 504.0 | |||||||||||
| Foreign | 378.6 | 329.8 | 64.9 | ||||||||||||||
Total Earnings from continuing operations before income taxes | $ | 1,107.5 | $ | 959.5 | $ | 568.9 | |||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Current tax expense: | |||||||||||||||||
| Federal | $ | 64.6 | $ | 125.9 | $ | 183.1 | |||||||||||
| State | 12.5 | 46.2 | 38.9 | ||||||||||||||
| Foreign | 55.1 | 60.4 | 44.6 | ||||||||||||||
| $ | 132.2 | $ | 232.5 | $ | 266.6 | ||||||||||||
Deferred tax expense (benefit): | |||||||||||||||||
| Federal | $ | 83.1 | $ | (6.3) | $ | (63.1) | |||||||||||
| State | 15.9 | (11.1) | (31.6) | ||||||||||||||
| Foreign | (1.4) | (2.7) | 16.6 | ||||||||||||||
| 97.6 | (20.1) | (78.1) | |||||||||||||||
Total Provision for income taxes | $ | 229.8 | $ | 212.4 | $ | 188.5 | |||||||||||
| Year Ended December 31, | |||||||||||||||||||||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||||||||||||||||||||
| Amount | % | Amount | % | Amount | % | ||||||||||||||||||||||||||||||
Statutory U.S. rate | $ | 232.6 | 21.0 | % | $ | 201.5 | 21.0 | % | $ | 119.5 | 21.0 | % | |||||||||||||||||||||||
State and local income taxes, net of federal income tax effects (1) | 24.3 | 2.2 | % | 23.4 | 2.4 | % | 2.7 | 0.5 | % | ||||||||||||||||||||||||||
Foreign tax effects: | |||||||||||||||||||||||||||||||||||
Canada: | |||||||||||||||||||||||||||||||||||
Deferred tax adjustments | 0.4 | — | % | 0.5 | 0.1 | % | 9.9 | 1.7 | % | ||||||||||||||||||||||||||
| Other | 1.1 | 0.1 | % | (2.5) | (0.3) | % | 3.3 | 0.6 | % | ||||||||||||||||||||||||||
Germany: | |||||||||||||||||||||||||||||||||||
Deferred tax adjustments | (0.2) | — | % | (0.2) | — | % | (6.8) | (1.2) | % | ||||||||||||||||||||||||||
| Other | 1.1 | 0.1 | % | 1.1 | 0.1 | % | 5.8 | 1.0 | % | ||||||||||||||||||||||||||
United Kingdom: | |||||||||||||||||||||||||||||||||||
Goodwill impairment | — | — | % | — | — | % | 39.1 | 6.9 | % | ||||||||||||||||||||||||||
Deferred tax adjustments | 0.3 | — | % | — | — | % | 12.9 | 2.3 | % | ||||||||||||||||||||||||||
| Other | (0.3) | — | % | (0.4) | — | % | 5.1 | 0.8 | % | ||||||||||||||||||||||||||
Switzerland: | |||||||||||||||||||||||||||||||||||
Foreign rate differential | (16.9) | (1.5) | % | (16.0) | (1.7) | % | (16.1) | (2.8) | % | ||||||||||||||||||||||||||
| Other | 2.7 | 0.2 | % | 3.8 | 0.4 | % | 0.6 | 0.1 | % | ||||||||||||||||||||||||||
Other foreign jurisdictions | (0.4) | — | % | (0.3) | — | % | 1.0 | 0.2 | % | ||||||||||||||||||||||||||
Enactment of new tax laws | — | — | % | — | — | % | — | — | % | ||||||||||||||||||||||||||
Effect of cross-border tax laws: | |||||||||||||||||||||||||||||||||||
| Other | 3.0 | 0.3 | % | 4.5 | 0.5 | % | 2.1 | 0.4 | % | ||||||||||||||||||||||||||
Tax credits: | |||||||||||||||||||||||||||||||||||
R&D tax credits | (16.2) | (1.5) | % | (18.0) | (1.9) | % | (13.2) | (2.3) | % | ||||||||||||||||||||||||||
| Other | (1.1) | (0.1) | % | (0.7) | (0.1) | % | (1.3) | (0.2) | % | ||||||||||||||||||||||||||
Valuation allowances | 0.5 | — | % | (1.4) | (0.1) | % | — | — | % | ||||||||||||||||||||||||||
Nontaxable or nondeductible items: | |||||||||||||||||||||||||||||||||||
Goodwill impairment | — | — | % | — | — | % | 18.1 | 3.2 | % | ||||||||||||||||||||||||||
Officer compensation | 8.3 | 0.7 | % | 6.9 | 0.7 | % | 9.9 | 1.7 | % | ||||||||||||||||||||||||||
Worthless stock loss | — | — | % | — | — | % | (14.8) | (2.6) | % | ||||||||||||||||||||||||||
| Other | 5.3 | 0.5 | % | 7.5 | 0.8 | % | 5.7 | 1.0 | % | ||||||||||||||||||||||||||
Changes in unrecognized tax benefits | (8.3) | (0.7) | % | 1.9 | 0.2 | % | (1.0) | (0.2) | % | ||||||||||||||||||||||||||
Other adjustments: | |||||||||||||||||||||||||||||||||||
Deferred tax adjustments | 0.1 | — | % | 3.2 | 0.3 | % | 6.4 | 1.1 | % | ||||||||||||||||||||||||||
| Other | (6.5) | (0.6) | % | (2.4) | (0.3) | % | (0.4) | (0.1) | % | ||||||||||||||||||||||||||
Effective tax rate | $ | 229.8 | 20.7 | % | $ | 212.4 | 22.1 | % | $ | 188.5 | 33.1 | % | |||||||||||||||||||||||
| December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Deferred tax assets: | |||||||||||
Derivative instruments | $ | 69.7 | $ | 36.5 | |||||||
| Employee compensation and benefits | 69.0 | 70.8 | |||||||||
| Operating lease liability | 198.0 | 199.3 | |||||||||
Credit carryforwards | 45.2 | 0.4 | |||||||||
Capitalized R&D costs | 98.2 | 194.7 | |||||||||
| Tax loss carryforwards | 226.4 | 224.0 | |||||||||
| Other | 118.2 | 114.3 | |||||||||
| Total gross deferred tax assets | 824.7 | 840.0 | |||||||||
| Less: valuation allowance | (128.1) | (127.2) | |||||||||
| Deferred tax assets, net of valuation allowance | $ | 696.6 | $ | 712.8 | |||||||
| Deferred tax liabilities: | |||||||||||
| Right of use asset | $ | (182.9) | $ | (181.6) | |||||||
| Intangible assets | (663.3) | (626.7) | |||||||||
| Property, plant, and equipment | (216.7) | (177.7) | |||||||||
| Other | (64.5) | (71.7) | |||||||||
| Total gross deferred tax liabilities | $ | (1,127.4) | $ | (1,057.7) | |||||||
| Net deferred tax liabilities | $ | (430.8) | $ | (344.9) | |||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Beginning balance | $ | 127.2 | $ | 150.2 | $ | 151.3 | |||||||||||
| Movements charged to expense | 0.3 | (22.8) | (8.9) | ||||||||||||||
| Reductions and other adjustments | 0.6 | (0.2) | 7.8 | ||||||||||||||
| Ending balance | $ | 128.1 | $ | 127.2 | $ | 150.2 | |||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Beginning balance | $ | 32.2 | $ | 29.9 | $ | 37.5 | |||||||||||
| Increase in reserve for tax positions taken in the current year | 2.2 | 2.2 | 1.8 | ||||||||||||||
| Increase in reserve for tax positions taken in a prior period | 5.5 | 3.8 | 10.4 | ||||||||||||||
| Decrease in reserve for tax positions taken in a prior period | (15.4) | (3.4) | (4.0) | ||||||||||||||
| Decrease in reserve as a result of settlements | — | (0.1) | (7.2) | ||||||||||||||
| Decrease in reserve as a result of lapses in the statute of limitations | — | (0.2) | (8.6) | ||||||||||||||
| Ending balance | $ | 24.5 | $ | 32.2 | $ | 29.9 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 24, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 26, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Feb 25, 2022 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Feb 28, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Feb 27, 2018 | |
| 2016 | Feb 27, 2017 | |
| 2015 | Feb 29, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.